Data from MMY1001 Study | Update from Lenalidomide Refractory Subgroup Kidney 1 Min Read0 Ajai Chari, MD, Mt. Sinai discusses Data from MMY1001 Study | Update from Lenalidomide Refractory Subgroup at Annual Meeting 2018
Kidney Cancer Experts at UT Southwestern discuss the CARMENA trial Kidney 1 Min Read0 Dr. Jim Brugarolas, Director of the UT Southwestern Kidney Cancer Program, sat down with expert urologist, Dr. Vitaly Margulis, and…